May 26, 2026 7:25 am EDT Kane Biotech Announces the Oversubscription and Closing of Private Placement Offering
May 13, 2026 7:25 am EDT Kane Biotech Presents Data To Global Wound Care Community at WCET®–NSWOCC® 2026 Joint Congress
Apr 16, 2026 7:25 am EDT Kane Biotech Presents revyve® Clinical Data at Symposium on Advanced Wound Care (SAWC) Spring Conference
Mar 17, 2026 7:25 am EDT Kane Biotech Announces Publication in Frontiers in Antibiotics Highlighting Advancements in Treating Antibiotic Tolerant Biofilms
Mar 10, 2026 7:25 am EDT Kane Biotech Expands U.S. Commercial Footprint with Strategic Distribution Partnership
Feb 20, 2026 7:25 am EST Kane Biotech Announces Publication of revyve® Wound Gel Article in the International Wound Journal
Feb 17, 2026 7:25 am EST Kane Biotech Announces FDA 510(k) Clearance for revyve® Antimicrobial Skin and Wound Cleanser
